Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14
PHASE3CompletedINTERVENTIONAL
Enrollment
130
Participants
Timeline
Start Date
October 31, 2005
Study Completion Date
February 28, 2006
Conditions
ADHD
Interventions
DRUG
Methylphenidate hydrochloride
Trial Locations (1)
Unknown
Novartis Investigational Site, Freiburg im Breisgau